Hemogenyx Pharmaceuticals (UK) Today
| HEMO Stock | 343.40 20.90 6.48% |
Performance0 of 100
| Odds Of DistressLess than 24
|
Hemogenyx Pharmaceuticals is selling for under 343.40 as of the 22nd of December 2024; that is 6.48 percent increase since the beginning of the trading day. The stock's lowest day price was 310.0. Hemogenyx Pharmaceuticals has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Hemogenyx Pharmaceuticals has reported 400 for 1 split on 13th of December 2024. The performance scores are derived for the period starting the 28th of November 2023 and ending today, the 22nd of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Hemogenyx Pharmaceuticals is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 3.5 M outstanding shares. More on Hemogenyx Pharmaceuticals PLC
Moving against Hemogenyx Stock
Hemogenyx Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hemogenyx Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hemogenyx Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO CoFounder | Vladislav Sandler | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Hemogenyx Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Hemogenyx Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsHemogenyx Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hemogenyx Pharmaceuticals' financial leverage. It provides some insight into what part of Hemogenyx Pharmaceuticals' total assets is financed by creditors.
| |||||
Hemogenyx Pharmaceuticals PLC (HEMO) is traded on London Exchange in UK and employs 17 people. Hemogenyx Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hemogenyx Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Hemogenyx Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hemogenyx Pharmaceuticals operates under Biotechnology sector and is part of Health Care industry. The entity has 3.5 M outstanding shares.
Hemogenyx Pharmaceuticals generates negative cash flow from operations
Check Hemogenyx Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Hemogenyx Pharmaceuticals is USD12.03 Million. Hemogenyx Pharmaceuticals retains 10.27 (percent) of its outstanding shares held by insiders and 0.79 (percent) owned by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Hemogenyx Ownership Details
Hemogenyx Pharmaceuticals Risk Profiles
Although Hemogenyx Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Hemogenyx Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.76 | |||
| Standard Deviation | 8.04 | |||
| Variance | 64.69 | |||
| Risk Adjusted Performance | (0.04) |
Hemogenyx Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hemogenyx Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.